Clinical Trial Update: Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial updating safety and efficacy of BAY94-9027 in previously treated male children with Hemophilia A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BAY94-9027

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED